Showing results (271-280 of 423) with videos related to

Sort By:
Pageof 43
Neurology|February 8, 2022
Immunophenotyping of Inclusion Body Myositis Blood T and NK CellsNamita A Goyal, Gérald Coulis, Jorge Duarte, et al.
International Urology and Nephrology|July 23, 2026
Temporal trends and sociodemographic determinants of time to nephrectomy in localized renal cell cancerMaximilian Filzmayer, Michele Petix, Leonardo Quarta, et al.
Plos Medicine|October 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trialSteven Perrin, Shafeeq Ladha, Nicholas Maragakis, et al.
Urologia Internationalis|July 15, 2026
Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after NephroureterectomyMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.
Annals of Surgical Oncology|August 5, 2026
Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval EraMaximilian Filzmayer, Michele Petix, Leonardo Quarta, et al.
World Journal of Surgical Oncology|July 21, 2026
Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinomaMaximilian Filzmayer, Leonardo Quarta, Michele Petix, et al.
Urologic Oncology|August 5, 2026
Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomyLeonardo Quarta, Michele Petix, Maximilian Filzmayer, et al.
Urologic Oncology|April 18, 2022
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicityGabriele Sorce, Francesco Chierigo, Rocco Simone Flammia, et al.
Annals of Surgical Oncology|May 22, 2025
Perioperative Complications and In-hospital Mortality After Cystectomy for Nonbladder Cancer Conditions Versus Radical Cystectomy for Bladder CancerNatali Rodriguez Peñaranda, Mario de Angelis, Carolin Siech, et al.
Pageof 43